HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Hammond, W. G. Articles by Benfield, J. R. Search for Related Content PubMed PubMed Citation Articles by Hammond, W. G. Articles by Benfield, J. R.

The Journal of Thoracic and Cardiovascular Surgery, Vol 101, 800-806, Copyright © 1991 by The American Association for Thoracic Surgery and The Western Thoracic Surgical Association

ARTICLES

Variable regression of experimental bronchial preneoplasia during carcinogenesis

WG Hammond, RL Teplitz and JR Benfield
Department of Surgery, University of California, Davis, Sacramento 95817.

It has been thought that squamous severe atypical metaplasia of the bronchus is reliably precancerous. The canine subcutaneous bronchial autograft model for studying the progression of epidermoid carcinogenesis (normal----regular squamous metaplasia----mild, moderate, and severe atypical metaplasia----squamous cell carcinoma) provides evidence that severe atypical metaplasia of the bronchial epithelium is reversible. Among 148 subcutaneous bronchial autografts that had serial sampling of the epithelium and exposure to implants of methylcholanthrene, severe atypical metaplasia was noted in 28 that received only a single implant. During the total carcinogen exposure (median 24.5 months), 9 of 28 (32%) developed squamous cell cancer, and 19 of 28 (68%) regressed toward normal. Severe atypical metaplasia was noted in 34 subcutaneous bronchial autografts that received two or more carcinogen implants: epidermoid cancer developed in 26 of 34 (76.5%), and regression toward or to normal occurred in 8 of 34 (23.5%). Severe atypical metaplasia was not detected in 53 subcutaneous bronchial autografts: 19 that received only a single implant and 34 that received two or more implants. Progression and regression occurred among these subcutaneous bronchial autografts in proportions similar to those found in subcutaneous bronchial autografts wherein severe atypical metaplasia was seen. Among 33 subcutaneous bronchial autografts initially studied after 6 months of exposure to carcinogen, progression to severe atypical metaplasia was seen 3 months later in 19 of 33 that had additional exposure; in the same interval regression of epithelial abnormalities occurred in 14 of 33 subcutaneous bronchial autografts that had no additional exposure (p less than 0.05). We have presented evidence that severe atypical metaplasia includes at least three cell populations: one committed to cancer without further stimulus, one that regresses despite further carcinogen exposure, and one that requires additional carcinogen to progress to cancer. At least in this model, severe atypical metaplasia is not inexorably precancerous. The subcutaneous bronchial autograft model is suitable for seeking biologic indicators of irreversibility.

This article has been cited by other articles:

				B. D. Vincent, M. Fraig, and G. A. Silvestri A Pilot Study of Narrow-Band Imaging Compared to White Light Bronchoscopy for Evaluation of Normal Airways and Premalignant and Malignant Airways Disease Chest, June 1, 2007; 131(6): 1794 - 1799. [Abstract] [Full Text] [PDF]

				D. Moro-Sibilot, F. Fievet, M. Jeanmart, S. Lantuejoul, F. Arbib, M.H. Laverriere, E. Brambilla, and C. Brambilla Clinical prognostic indicators of high-grade pre-invasive bronchial lesions Eur. Respir. J., July 1, 2004; 24(1): 24 - 29. [Abstract] [Full Text] [PDF]

				C. Paris, J. Benichou, and L. Thiberville Re: Sex-Related Differences in Bronchial Epithelial Changes Associated With Tobacco Smoking J Natl Cancer Inst, February 5, 2003; 95(3): 242 - 243. [Full Text] [PDF]

				S. BOTA, J.-B. AULIAC, C. PARIS, J. METAYER, R. SESBOUE, G. NOUVET, and L. THIBERVILLE Follow-up of Bronchial Precancerous Lesions and Carcinoma in Situ Using Fluorescence Endoscopy Am. J. Respir. Crit. Care Med., November 1, 2001; 164(9): 1688 - 1693. [Abstract] [Full Text] [PDF]

				N. Martinet, F. Alla, G. Farre, T. Labib, H. Drouot, R. Vidili, E. Picard, M.-P. Gaube, D. Le Faou, J. Siat, et al. Retinoic Acid Receptor and Retinoid X Receptor Alterations in Lung Cancer Precursor Lesions Cancer Res., June 1, 2000; 60(11): 2869 - 2875. [Abstract] [Full Text] [PDF]

				E. Brambilla, S. Gazzeri, D. Moro, S. Lantuejoul, S. Veyrenc, and C. Brambilla Alterations of Rb Pathway (Rb-p16INK4-Cyclin D1) in Preinvasive Bronchial Lesions Clin. Cancer Res., February 1, 1999; 5(2): 243 - 250. [Abstract] [Full Text] [PDF]